Amsterdam Molecular Therapeutics, San Raffaele Telethon Institute for Gene Therapy deal

Amsterdam Molecular Therapeutics received undisclosed rights to San Raffaele Telethon Institute’s microRNA technology. Amsterdam will use the technology to prevent immune responses in the development ...